Therapeutic Direction and Issues Regarding HBV Infection

Document Type : Review

Authors

1 Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran

2 Center for General Education, Chang Gung University, Wei-Hwa, Kwei-Shan, Tao-Tuan 333, Taiwan

Abstract

With up to 400 million affected people worldwide, chronic hepatitis B virus (HBV) infection is still a major health care problem. During the last decade, several novel therapeutic approaches have been developed and evaluated. In most regions of the world, interferon-α (IFN-α), and nucleos(t)ide analogues are currently approved. Despite major improvements, none of the existing therapies is optimal since viral clearance is rarely achieved. HBV establishes a stable nuclear covalently closed circular DNA (cccDNA). Interferon-α treatment can clear HBV but is limited by systemic side effects. Up-regulation of APOBEC3A and APOBEC3B enzymes by use of IFN-α or lymphotoxin-b (LT bR) was found to result in cytidine deamination, apurinic/apyrimidinic site formation, and finally cccDNA degradation that prevented HBV reactivation, while genomic DNA was found to remain intact. As such, development of new therapeutics in combination with existing antivirals, may cure hepatitis B. With respect to the selectivity observation on the activation of LTβR, however, more studies are necessary on the potential utility of LTβR agonists for clearance of cccDNA in chronic hepatitis B (CHB). HBV is a DNA virus that can integrate DNA into host genome thereby increases the yield of trans-activator protein HBxAg that may deregulate many pathways involving in metabolism of cells causing Hepatocellular Carcinoma (HCC) development. This review aimed at therapeutic direction and issues regarding HBV infection.

Graphical Abstract

Therapeutic Direction and Issues Regarding HBV Infection

Keywords

Main Subjects

References

 
 
[1]         A.S.F. Lok, B.J. McMahon, Hepathology 45 (2007) 507; Y.F. Liaw, Antivir Ther.11 (2006) 669; D. Grimm, R. Thimme, H.E. Blum, Hepatol Int. 5 (2011) 644; http://www.who.int/mediacentre/factsheets/ fs204/en/
[2]         B.J. McMahon, C.M. Dentinger, D. Bruden, C. Zanis, H. Peters, D. Hurlburt, L. Bulkow, A.E. Fiore, B.P. Bell, T.W. Hennessy, J. Infect. Dis.200 (2009) 1390; W.H. Gerlich, Virology J. 10 (2013) 239.
[3]         H.E. Kohrt, D.L. Ouyang, E.B. Keeffe, Clin. Liver Dis. 11 (2007) 965; S. Locarnini, C.Birch, J. Hepatol.30 (1999) 536; C. Hsu, H.H. Tsou, S.J. Lin, M.C. Wang, M. Yao, W.L. Hwang, W.Y. Kao, C.F. Chiu, S.F. Lin, J. Lin, C.S. Chang, H.F. Tien, T.W. Liu, P.J. Chen, A.L. Cheng, Hepathology 59 (2014) 2092; Y.-H. Huang, H.-C. Lin, S.-D. Lee, J. Chin. Med. Assoc. 75 (2012) 359.

[4]         J. Feld, J.-Y. Lee, S. Locarnini, Hepatology38 (2003) 545; http://www.hepb.org/patients/hepatitis_b_ clinical_ trials.htm

[5]         J.L. Dienstag, N Engl. J. Med. 359 (2008) 1486; G. Papatheodoridis, M. Buti, M. Cornberg, H. Janssen, D. Mutimer, S. Pol, G. Raimondo, J. Hepatol. 57 (2012) 167.
[6]         V. Kumar, N. Fausto, A. Abbas (Eds.), Robbins & Cotran Pathologic Basis of Disease (7th ed.). Saunders, 2003, pp. 914-7. ISBN 978-0-7216-0187-8; http://www.mayoclinic.com/health/liver-cancer/DS00399/DSECTION=symptoms; X.W. Wang, S.P. Hussain, T.-I. Huo, C.-G. Wu, M. Forgues, L.J. Hofseth, C. Brechot, C.C. Harris, Toxicology 181-182 (2002) 43.
[7]         A.S. Lok, B.J. McMahon, Hepatology 50 (2009) 661;  G. Papatheodoridis, M. Buti, M. Cornberg, H.L. Janssen, D. Mutimer, S. Pol, G. Raimondo, G. Dusheiko, A. Lok, P. Marcellin, J. Hepatol. 57 (2012)   167; http://www.uptodate.com/contents/hepatitis- b-beyond-the-basics.
[8]         B. Hepatities, Foundation: http://www.hepb.org/ professionals/acute_vs._chronic_hbv.htm; WHO Global Alert and Response:  http://www.who.int/csr/ disease/hepatitis/whocdscsrlyo20022/en/index1.html;  Medline Plus:  http://www.nlm.nih.gov/medlineplus/ ency/article/000279.htm.
[9]         Y.-F. Liaw, M.R. Brunetto, S. Hadziyannis, Antivir. Ther.15 (2010) 25.
[10]     C.K. Hui, C.K. Lau, J. Clin. Virol. 34 (2005) S44.
[11]     R. D’Souza, G.R. Foster, JR Soc. Med. 97 (2004) 318.
[12]     J. Petersen, M. Lutgehetmann, T. Volz, M. Dandri, Hepatol. Rev. 4 (2007) 9.
[13]     J. Lucifora, Y. Xia, F. Reisinger, K. Zhang, D. Stadler, X. Cheng, M.F. Sprinzl, H. Koppensteiner, Z. Makowska, T. Volz, C. Remouchamps, W.-M. Chou, W.E. Thasler, N. Hüser, D. Durantel, T.J. Liang, C. Münk, M.H. Heim, J.L. Browning, E. Dejardin, M. Dandri, M. Schindler, M. Heikenwalder, U. Protzer, Science343 (2014) 1221.
[14]     F. Zoulim, Liver Int.31 (2011) 111.
[15]     K. Wursthorn, M. Lutgehetmann, M. Dandri, T. Volz, P. Buggisch, B. Zollner, T. Longerich, P. Schirmacher, F. Metzler, M. Zankel, C. Fischer, G. Currie, C. Brosgart, J. Petersen, Hepatology 44 (2006) 675.
[16]     R. Suspène, D. Guétard, M. Henry, P. Sommer, S. Wain-Hobson, J.P. Vartanian, Proc. Natl. Acad. Sci. U.S.A.102 (2005) 8321; H.P. Bogerd, H.L. Wiegand, B.P. Doehle, K.K. Lueders, B.R. Cullen, Nucleic Acids Res. 34 (2006) 89; L.G. Guidotti, K. Ando, M.V. Hobbs, T. Ishikawa, L.I. Runke, R.D. Schreiber, FV. Chisari, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3764.
[17]     L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, F.V. Chisari, Science 284 (1999) 825.
[18]     S.F. Wieland, H.C. Spangenberg, R. Thimme, R.H. Purcell, F.V. Chisari, Proc. Natl. Acad. Sci. U.S.A.101 (2004) 2129.
[19]     H. McClary, R. Koch, F.V. Chisari, L.G. Guidotti, J. Virol. 74 (2000) 2255.
[20]     L. Belloni, L. Allweiss, F. Guerrieri, N. Pediconi, T. Volz, T. Pollicino, J. Petersen, G. Raimondo, M. Dandri, M. Levrero, J. Clin. Invest.122 (2012) 529.
[21]     G.H. Hakimelahi, T.W. Ly, A.A. Moosavi-Movahedi, M.L.  Jain,  M.  Zakerinia,  H. Davari, H.-C. Mei,
 
 
TSambaiah, A.A. Moshfegh, S. Hakimelah, J. Med. Chem. 44 (2001) 3710; M.F. Sorrell, E.A. Belongia, J. Costa, I.F. Gareen, J.L. Grem, J.M. Inadomi, et al.  Ann. Intern. Med. 150 (2009) 104.
[22]     G. Nebbia, D. Peppa, M.K. Maini, QJM. 105 (2012) 109.
[23]     A.S. Lok, B.J. McMahon, Hepatology 50 (2009) 661.
[24]     G. Papatheodoridis, M. Buti, M. Cornberg, et al. J. Hepatol. 57 (2012) 167.
[25]     Y.F. Liaw, N. Leung, J.H. Kao, T. Piratvisuth, E. Gane, K.H. Han, et al. Hepatol Int.2 (2008) 263.
[26]          M. Sherman, S. Shafran, K. Burak, K. Doucette, W. Wong, N. Girgrah, et al. Can. J. Gastroenterol. 21 (2007) 5C.
[27]          P.T. Kennedy, H.C. Lee, L. Jeyalingam, R. Malik, P. Karayiannis, D. Muir, et al. Antivir. Ther.13 (2008) 1067.
[28]     Z. Fox, U.B. Dragsted, J. Gerstoft, A.N. Phillips, J. Kjaer, L. Mathiesen, M. Youle, C. Katlama, A. Hill, J.N. Bruun, N. Clumeck, P. Dellamonica, J.D. Lundgren, Antivir. Ther.11 (2006) 761.
[29]     P. Marcellin, T.T. Chang, S.G. Lim, et al. N. Engl. J. Med. 348 (2003) 808; S. Manolakopoulos, S. Bethanis, S. Koutsounas, et al. Aliment. Pharmacol. Ther. 27 (2008) 266.
[30]     K.A. Sims, A.M. Woodland, Pharmacotherapy 26 (2006) 1745.
[31]     B.P. Kearney, K. Yale, J. Shah, L. Zhong, J.F. Flaherty, Clin. Pharmacokinet. 45 (2006) 1115.
[32]     C.L. Lai, N. Leung, E.K. Teo, et al.  Gastroenterology129 (2005) 528; C.L. Lai, E. Gane, Y.F. Liaw, et al. N Engl. J. Med. 357 (2007) 2576;  H.L. Chan, E.J. Heathcote, P. Marcellin, et al. Ann. Intern. Med. 147 (2007) 745.
[33]     H. Janssen, Lancet 365 (2005) 123; G.K.K. Lau, et al.  New Engl. J. Med. 352 (2005) 2682; J.L. Dienstag, Chronic viral hepatitis. In GL Mandell et al. (Eds.), Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, 2010  pp. 1593-1670. Philadelphia: Churchill Livingstone Elsevier; http://www.medicinenet.com/interferon/ article.htm.
[34]     US Department of Health and Human Services: Viral Hepatitis Therapies. http://www.fda.gov/ ForConsumers/ByAudience/ForPatientAdvocates/ucm151494.htm.
[35]     N.A. Terrault, Hepatology 49 (2009) S122; A.M. Di Bisceglie, Gut 50 (2002) 443.
[36]     D. Bhattacharya, C.L. Thio, Clin. Infect. Dis. 51 (2010) 1201.
[37]     I. Carey, P.M. Harrison, Expert. Opin. Investig. Drugs. 18 (2009) 1655.
[38]     M. Fasano, P. Lampertico, A. Marzano, V. Di Marco, G.A. Niro, G. Brancaccio, A. Marengo, G. Scotto, M.R. Brunetto, G.B. Gaeta, M. Rizzetto, G. Angarano, T. Santantonio, J. Hepatol. 56 (2012) 1254.
[39]     T. Tram, M.D. Tran, “Hepatitis B Management in Special Populations”, Eds. Zeuzem S, Afdhal NH.  Last Reviewed: 4/18/14 (http://www.inpractice.com/ Textbooks/Hepatology/ch5_Hep_B_Spec_Populations/Chapter-Pages/Page-1.aspx).
[40]     T. Starzl, T. Marchioro, K. VonKaulla, G. Hermann, R. Brittain, W. Waddell, Surg. Gynecol. Obstet. 117 (1963) 659; T.E. Starzl, G.B. Klintmalm, K.A. Porter, S. Iwatsuki, G.P. Schroter, New Engl. J. Med. 305 (1981) 266.
[41]     NVHR. National Viral Hepatitis Roundtable Warns Systemic Underfunding of Federal Viral Hepatitis Programs Puts Five Million Americans at Risk.  Press release. March 16, 2010; http://nvhr.org/; http://nvhr.org/nvhr-press-room; http://i-base.info/ htb/13584.
[42]     S.G. Lim, T.M. Ng, N. Kung, Z. Krastev, M. Volfova, P. Husa, S.S. Lee, S. Chan, M.L. Shiffman, M.K. Washington, A. Rigney, J. Anderson, E. Mondou, A. Snow, J. Sorbel, R. Guan, F. Rousseau, Arch. Intern. Med. 166 (2006) 49.
[43]     H.S. Lee, Y.H. Chung, K. Lee, K.S. Byun, S.W. Paik, J.Y. Han, K. Yoo, H.W. Yoo, J.H. Lee, B.C. Yoo,  Hepatology 43 (2006) 982.
[44]     C.L. Lai, S.H. Ahn, K.S. Lee, S.H. Um, M. Cho, S.K. Yoon, J.W. Lee, N.K. Park, Y.O. Kweon, J.H. Sohn, J. Lee, J.A. Kim, K.H. Han, M.F. Yuen, Gut. 63 (2014) 996; M.F. Yuen, K.H. Han, S.H. Um, S.K. Yoon, H.R. Kim, J. Kim, C.R. Kim, C.L. Lai, Hepatology 51 (2010) 767.
[45]     M. Brodszki, B. Bäckström, K. Horvath, T.  Larsson, H. Malmgren, M. Pelcman, H. Wähling, H. Wallberg, J. Wennerberg, Org. Process Res. Dev. 15 (2011) 1027.
[46]     T. Bader, B. Korba, 86 (2010) 241; L. Highleyman, 59th Annual Meeting of the American Association for the Study of Liver Diseases:, Oct. 31-Nov. 4 San Francisco, 2008,  CA;  http://clinicaltrials.gov/ show/NCT00994773.
[47]     N. Brezillon, M.N. Brunelle, H. Massinet, E. Giang, C. Lamant, L. Dasilva, S. Berissi, J. Belghiti, L. Hannoun, G. Puerstinger, E. Wimmer, J. Neyts, O. Hantz, P. Soussan, S. Morosan, D. Kremsdorf, PLoS ONE (www.plosone.org) 6 (2011) e25096.
[48]     M.-L. Michel, Q. Deng, M. Mancini-Bourgine, J. Hepatol. 54 (2011) 1286 and references cited therein; A. Bertoletti, A.J. Gehring, PLOS Pathogens 9 (2013) e1003784; http://www.drugs.com/ppa/hepatitis-b- immune-globulin-hbig.html; http://www.webmd.com/ hepatitis/tc/hepatitis-immunoglobulin-hbig-topic-overview.
[49]     http://www.hepb.org/professionals/hbf_drug_watch.htm;  N. Cox, H. Tillmann, Expert. Opin. Emerg. Drugs 16 (2011) 713; Perrillo RP. Seminars in liver disease 24 (2004) 23.
[50]     G. Carraro, A. Naso, E. Montomoli, R. Gasparini, R. Camerini, D. Panatto, M.C. Tineo, L. De Giorgi, S. Piccirella, B. Khadang, M. Ceracchi, A. De Rosa, Vaccine. 30 (2012) 1170; http://www.sciclone.com/product- portfolio/zadaxin/.

[51]     C.H.T. Miller, S.G. Maher, H.A. Young, Annals of the New YorkAcademy of Sciences 1182 (2009) 69.

[52]     M.-A. Perales, J.D. Goldberg, J. Yuan, G. Koehne, L. Lechner, H. Gallardo, C. Liu, T. Rasalan, J.D. Wolchok, T.M. Croughs Morre, S.M. Devin, E.B. Papadopoulos, J.W. Young, A. Ann, A.A. Jakubowski, B. Zaidi, H. Devlin, R. Marcel, M.R.M. van den Brink, Blood 120 (2012) 4882.
[53]     M.E. Major, L. Vitvitski, M.A. Mink, M. Schleef, R.G. Whalen, C. Trépo, G. Inchauspé, J. Virol.69 (1995) 5798. 
[54]     C.Y. Kim, E.S. Kang, S.B. Kim, H.E. Kim, J.H. Choi, D.S. Lee, S.J. Im, S.H. Yang, Y.C. Sung, B.M. Kim, B.-G. Kim, Exp. Mol. Med. 40 (2008) 669.
[55]     D.  Brett,  B.D.  Lindenbach,  B.M.  Prágai,  R. Montserret, R.K.F. Beran, A.M. Pyle, F. Penin, C.M. Rice, J. Virol. 81 (2007) 8905.
[56]     D. Batdelger, D. Dandii, Y. Dahgwahdorj, E. Erdene, J. Oyunbileg, N. Tsend, B. Bayarmagnai, V. Jirathitikal, A.S. Bourinbaiar, Curr. Pharm. Design 15 (2009) 1159; Ralph Braun US Patent 20060088542 A1.
[57]     P. Pushko, P. Pumpens, E. Grens, Intervirology 56 (2013) 141.
[58]     C. Cooper, D.Mackie, Expert Review of Vaccines 10 (2011) 417; http://informahealthcare.com/doi/full/ 10.1586/ erv.10.162; N.F. Eng, N. Bhardwaj, R. Mulligan, F. Diaz-Mitoma, Human Vaccines & immunotherapeutic 9 (2013) 1609.
[59]     W.H. Caselmann, M. Meyer, S. Scholz, P.H. Hofschneider, R. Koshy, J. Infect. Dis. 166 (1992) 966.
[60]     J. Lucifora, S. Arzberger, D. Durantel, L. Belloni, M. Strubin,
M. Levrero, F. Zoulim, O. Hantz, U. Protzer, J. Hepatol. 55 (2011) 996.
[61]     G. Robertson, M. Hirst, M. Bainbridge, M. Bilenky, Y. Zhao, T. Zeng, G. Euskirchen, B. Bernier, R. Varhol, A. Delaney, N. Thiessen, O.L. Griffith, A. He, M. Marra, M. Snyder, S. Jones, Nat. Methods 4 (2007) 651; B. Testoni, C. Völlenkle, F. Guerrieri, S. Gerbal-Chaloin, G. Blandino, M.  Levrero, J. Biol. Chem. 286 (2011) 20217.
[62]     L. Belloni, L. Allweiss, F. Guerrieri, N. Pediconi, T. Volz, T. Pollicino, J. Petersen, G. Raimondo, M.. Dandri, M.  Levrero, J. Clin. Invest. 122(2012) 529 and references cited therein.
[63]     F.V. Chisari, M. Isogawa, S.F. Wieland, Pathol. Biol. (Paris) 58 (2010) 258; H. Guo, D. Jiang, T. Zhou, A. Cuconati, T.M. Block, J.T. Guo, J. Virol. 81 (2007) 12472; H.T. Guo, R.C. Mao, T.M. Block, J.T. Guo, J. Virol. 84 (2010) 387; J. Summers, A.O. Connell, I.Millman, Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 4597; J. Chang, F. Guo, X. Xuesen Zhao, J.-T. Guo, Acta Pharmaceutica Sinica B(2014) in press, http://dx.doi.org/10.1016/ j.apsb.2014.05.002; J. Summers, W.S. Mason, Cell29 (1982) 403; G.H. Wang, C. Seeger, J. Virol. 67 (1993) 6507.
[64]     J.J. Chang, F. Wightman, A. Bartholomeusz, A. Ayres, S.J. Kent, J. Sasadeusz, S.R. Lewin, J. Virol. 79
 
 
(2005) 3038.
[65]     F.V. Chisari, C. Ferrari, Annu. Rev. Immunol. 13 (1995) 29.
[66]     M. Iannacone, G. Sitia,Z.M. Ruggeri,L.G. Guidotti,J. Hepatol. 46 (2007) 719.
[67]     Y. Suzuki, M. Kobayashi, K. Ikeda, F. Suzuki, Y. Arfase, N. Akuta, T. Hosaka, S. Saitoh, M. Kobayashi, T. Someya, M. Matsuda, J. Sato, S. Watabiki, Y. Miyakawa, H. Kumada, J. Med. Virol. 76 (2005) 33.
[68]     D. Azoulay, J. Hepatol. (2014) Jun 20. pii: S0168-8278(14)00448-6. doi: 10.1016/j.jhep.2014.06.018. [Epub ahead of print]; M. Thomas, A. Zhu, J. Clin. Oncol. 23 (2005) 2892.
[69]     S. Günther, G. Sommer, F. Von Breunig, A. Iwanska, T. Kalinina, M. Sterneck, H. Will, J. Clin. Microbiol. 36 (1998) 531.
[70]     H. Yan, G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, Y. Huang, Y. Qi, B. Peng, H. Wang, L. Fu, M. Song, P. Chen, W. Gao, B. Ren, Y. Sun, T. Cai, X. Feng, J. Sui, W. Li, (2012). ELife 1: e00049.
[71]     S. Quan, P. Koldewey, T. Tapley, N. Kirsch, K.M. Ruane, J. Pfizenmaier, R. Shi, S. Hofmann, L. Foit,  G. Ren, U. Jakob, Z. Xu, M. Cygler, J.C.A.  Bardwell, Nat. Struct. Mol. Biol. 18 (2011) 262.
[72]     C. Seeger, W.S. Mason, Microbiol. Mol. Biol. Rev. 64 (2000) 51.
[73]     M. Melegari, S.K. Wolf, R.J. Schneider, J. Virol. 79 (2005) 9810.
[74]     J. Beck, M. Nassal, World J. Gastroenterol. 13 (2007) 48; V. Bruss, World J. Gastroenterol. 13 (2007) 65; http://en.wikipedia.org/wiki/Hepatitis_B; http:// www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index2.html#life.
[75]     A. Kramvis, M. Kew, G. François, Vaccine 23 (2005) 2409.
[76]     H. Norder, A.M. Couroucé, L.O. Magnius, Virology 198 (1994) 489; S. Schaefer, World J. Gastroenterol.13 (2007) 14.
[77]     F. Kurbanov, Y. Tanaka, A. Kramvis, P. Simmonds, M. Mizokami, J. Virol. 82 (2008) 8241; E. Palumbo, Am. J. Ther. 14 (2007) 306; M.A. Mahtab, S. Rahman, M. Khan, F. Karim, Hbpd. Int. 7 (2008) 457.
[78]     D. Grimm, R. Thimme, H.E. Blum, Hepatol. Int. 5 (2011) 644 and references cited therein.
[79]     B. Werle-Lapostolle, S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, G. Lau, C. Trepo, P. Marcellin, Z. Goodman, W.E. Delaney, S. Xiong, C..L. Brosgart, S.S. Chen, C.S. Gibbs, F. Zoulim, Gastroenterology 126 (2004) 1750; J. Petersen, M. Lutgehetmann, T. Volz, M. Dandri, Hepatology Rev. 4 (2007) 9.
[80]     M.M. Jonas, D. Kelly, H. Pollack, J. Mizerski, J. Sorbel, D. Frederick, E. Mondou, F. Rousseau, E. Sokal, Pediatr Infect. Dis. J. 31 (2012) 578.
[81]     E. Arrese, M. Basaras, S. Blanco, P. Ruiz, R. Cisterna,  Ann. Hepatol. 10 (2011) 434.
[82]      F. Zoulim, J. Antimicrob. Chemother. 55 (2005) 608.
[83]     J. Feld, J.-Y. Lee, S. Locarnini, Hepatology 38 (2003) 545; Y.-H. Chow, B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W.-C. Lin, Y.-T. Chen, M.-H. Tao, J. Immunology 160 (1998) 1320.
[84]     E. Mizukoshi, J. Sidney, B. Livingston, M. Ghany, J.H. Hoofnagle, A. Sette, B. Rehermann, J. Immunology 173 (2004) 5863; Hepatology 24 (1996) 991.
[85]     C.-K. Hui, G.K.K. Lau, Int. J. Med. Sci.2 (2005) 24; Y. Zhu, JHVRV 1 (2014) 1.
[86]     C.-M. Tang, T.O. Yau, J. Yu, World J. Gastroenterol. 20 (2014)6262; http://virtualpressoffice.easl.eu/ press-release---novel-therapeutic-approches-to-cure-chronic-hbv-infection/.
[87]     C. Li, P.S. Norris, C.Z. Ni, M.L. Havert, E.M. Chiong,  B.R. Tran, E. Cabezas, J.C. Reed, A.C. Satterthwait, C.F. Ware, K.R. Ely, J. Biol. Chem. 278 (2003) 50523;  F. Mackay, G.R. Majeau, P.S. Hochman, J.L. Browning, J. Biol. Chem. 271 (1996) 24934.
[88]     M.D. Stenglein, M.B. Burns, M. Li, J. Lengyel, R.S. Harris, Nat. Struct. Mol. Biol. 17 (2010) 222; T. Burton, Molecular Biology, M.A. Sudbury, Jones & Bartlett Learning, 2012, p. 455; J.M. Pascal, P.J. O'Brien, A.E. Tomkinson, T.  Ellenberger, Nature 432 (2004) 473.
[89]     K. Kitamura, Z. Wang, S. Chowdhury, M. Simadu, et al. PLoS Pathog 9 (2013) e1003361.
[90]     K. Krebs, N. Bottinger, L.-R. Huang, M. Chmielewski, S. Arzberger, G. Gasteiger, C. Jager, E. Schmitt, F. Bohne, M. Aichler, W. Uckert, H. Abken, M. Heikenwalder, P. Knolle, U. Protzer, Gastroenterology 145 (2013) 456.
[91]     M. Lukashev, D. LePage, C. Wilson, V. Bailly, E. Garber, A. Lukashin, A. Ngam-ek, W. Zeng, N. Allaire, S. Perrin, X. Xu, K. Szeliga, K. Wortham, R. Kelly, C. Bottiglio, J. Ding, L. Griffith, G. Heaney, E. Silverio, W. Yang, M. Jarpe, S. Fawell, M. Reff, A. Carmillo, K. Miatkowski, J. Amatucci, T. Crowell, H. Prentice, W. Meier, S.M. Violette, F. Mackay, D. Yang, R. Hoffman, J.L. Browning, Cancer Res. 66 (2006) 9617.
[92]     F.V. Chisari, W.S. Mason, C. Seeger, Science 344 (2014) (6189) 1237;  http://www.giga.ulg.ac.be/jcms/ prod_1764076/en/lymphotoxin-beta-receptor-and-degradation-of-hbv-cccdna.
[93]     E. Zorde-Khvalevsky, R. Abramovitch, H. Barash, I. Spivak-Pohis, L. Rivkin, J. Rachmilewitz, E. Galun, H. Giladi, Hepatology 50 (2009) 198.
[94]     R.A. Anders, K.S Subudhi, J. Wang, K. Pfeffer, Y.-X.  Fu, J. Immunol.175 (2005) 1295.
[95]     M.J. Wolf, G.M. Seleznik, N. Zeller, M. Heikenwalder, Oncogene 29 (2010) 5006.
[96]     H.C. Smith, R.P. Bennett, .A Kizilyer, W.M. McDougall, K.M. Prohaska, Semin. Cell Dev. Biol. 23(2012) 258.
[97]     M. Allison A.M. Land, E.K. Law, M.A. Carpenter, L. Lackey, W.L. Brown, R.S. Harris, J. Biol. Chem. 288(2013) 17253.
[98]     http://www.nextprot.org/db/entry/NX_Q96RU7; K. Du, S. Herzig, R.N. Kulkarni, M. Montminy, Science 300 (2003) (5625) 1574.
[99]     X. Hu, M.A. Zimmerman, K. Bardhan, D. Yang, J.L. Waller, G.B. Liles, J.R. Lee, R. Pollock, D. Lev, C.F. Ware, E. Garber, V. Bailly, L. Jeffrey, J.L. Browning, K. Liu, Carcinogenesis 34 (2013) 1105.
[100]  J. Haybaeck, N. Zeller, M.J. Wolf, A. Weber, U. Wagner, M.O. Kurrer, J. Bremer, G. Lezzi, R. Graf, P.-A. Clavien, et al. Cancer Cell 16 (2009) 295.
[101]  D. Sir, Y. Tian, W.-L. Chen, D.K. Ann, T.Z.B. Yen, J.-H.J. Ou, PNAS 107 (2010) 4383.
[102]  Y.W. Hong, J. Ding, Cancer Gene. 8 (2011) 337; J. Haybaeck, N. Zeller, M.J. Wolf, et al. Cancer Cell 16 (2009) 295.
[103]  M.A. Sameh, R. He, Int. J. Hepatol. 2011 (2011) 1.
[104]  N.C. Teoh, Hepatology 52 (2010) 384.
[105]  N. Li, S.I. Grivennikov, M. Karin, Cancer Cell 19 (2011) 429.
[106]  V.W.-S. Wong, J. Yu, A.S.-L. Cheng, et al. Int. J. Cancer 124 (2009) 2766.
[107]  A. Arzumanyan V.M. Sambandam, V. Clayton, et al. Cancer Res. 72 (2012) 5912.
[108]  C.J. Yen, Y.-J. Lin, S.-C. Yen, et al. PLoS One 7 (2012) e41931.
[109]  C. Coulouarn, V.M. Facto, E.A. Conner, S.S. Thorgeirsson. Carcinogenesis 32 (2011) 1434.
[110]  R.-H. Fan, J. Li, N. Wu, P.-S. Chen, World J. Gastroenterol. 17 (2011) 3420.
[111]  Y. Qin, J.-Y. Liu, B. Li, Z.-L. Sun, Z.-F. Sun, World J. Gastroenterol. 10 (2004) 1276.
[112]  T. Severi, C. Ying, J.R. Vermeesch, et al. Mol. Cell. Biochem. 290 (2006) 79.
[113]  M.-W. Yu, S.-Y. Yang, I.-J. Pan, et al. J. Nat. Cancer Inst.95 (2003) 1485. 
[114]  A. Ayub, U.A. Ashfaq, A. Haque. Bio. Med. Res. Int. (2013) 1.
[115]  D. Ganem, A.M. Prince, N Engl. J. Med. 350 (2004) 1118.
[116]  B. Werle-Lapostolle, S. Bowden, S. Locarnini, et al. Gastroenterology 126 (2004) 1750.
[117]  A. Laras, J. Koskinas, E. Dimou, A. Kostamena, S.J. Hadziyannis, Hepatology 44 (2006) 694.
[118]  T.M. Abraham, D.D. Loeb. J. Virol. 81 (2007) 11577.
[119]  C.L. Chong, M.L. Chen, Y.-C. Wu, et al. J. Biomed. Sci. 18 (2011) article 96.
[120]  K. Wursthorn, M. Lutgehetmann, M. Dandri, et al. Hepatology 44 (2006) 675.
[121]  H.L.-Y. Chan, V.W.-S. Wong, A.M.-L. Tse, et al. Clin. Gastroenterol. Hepatol. 5 (2007) 1462.
[122]  F. van Bommel, B. Zollner, C. Sarrazin, et al. Hepatology 44 (2006) 318.
[123]  T. Hosaka, F. Suzuki, M. Kobayashi, et al. Liver Int. 30 (2010) 1461.
[124]   Liver EAftSot:  in Novel Therapeutic Approaches May Cure Chronic HBV Infection, ScienceDaily, Rockville, Md, USA, 2013.
[125]  T. Hosaka, F. Suzuki, M. Kobayashi, M. Hirakawa, Y. Kawamura, H. Yatsuji, H. Sezaki, N. Akuta, Y. Suzuki, S. Saitoh, Y. Arase, K. Ikeda, M. Kobayashi, H. Kumada, Liver Int. 30 (2010) 1461.
 

Files

Share

How to cite

Statistics